Statins May Treat MS Symptoms
Statins could be an effective advanced multiple sclerosis treatment according to the results of earlystage trials now published by The Lancet medical journal.The findings indicate that medications...
View ArticleLifethreatening Atherosclerosis Now Affordably Treatable
AffordRx offers free discount cards for Lovaza and other atherosclerosis medications.Margate NJ PRWEB March 19 2014 Atherosclerosis is a scarysounding word that refers to a common condition that if...
View ArticleNew heart guidelines may put 12.8 million more Americans on statins
CHICAGO March 19 Reuters New guidelines on heart health that sparked fierce debate among U.S. cardiologists last fall could lead 12.8 million more Americans to take cholesterollowering statin drugs...
View ArticleAlmost 13 Million More Americans Could Take Statins Under New Guidelines
WEDNESDAY March 19 2014 Nearly 13 million more Americans will be eligible to take cholesterollowering statin drugs under new guidelines and most of those additional users will be older than 60...
View ArticleHalf Of Adults 40 To 75 Eligible For Statins
Almost half of Americans ages 40 to 75 and nearly all men over 60 qualify to consider cholesterollowering statinÂdrugsÂunder new heart disease prevention guidelines an analysis concludes.Read more...
View ArticleWhy the 'Statin Witch Hunt'
Dr. Frank Veith takes issue with objections raised by the medical community and lay press about new AHA guidelines recommending the expanded use of statin drugs. Medscape General Surgery
View ArticleNew Guidance Will Up Statin Use by 13 Million CMECE
MedPage Today An additional 12.8 million Americans ages 40 to 75 are eligible for statin therapy under the latest guidelines from the American College of Cardiology and the American Heart Association...
View ArticleStudy Finds New Heart Guidelines Would Put About Half Of Older Adults On Statins
The New England Journal of Medicine study is the first independent assessment of guidelines released last fall on the use of the heart medications and it shows 56 million people between the ages of 40...
View ArticlePromising Biotechs Target New Ways to Kill Bad Bugs Venture Capitalist Dennis...
The Life Sciences Report As a venture capitalist your investments are the feedstock of the initial public offering IPO markets and you must constantly think about getting your private equity holdings...
View ArticleDiabetes caused by Lipitor Lawsuits Filed by Two Kansas Women Reports Janet...
KANSAS CITY Kan. March 24 2014 PRNewswire &160;Two Kansas women who took Lipitor to reduce their cholesterol levels and later developed diabetes have filed Lipitor lawsuits against Pfizer announced...
View ArticlePhase 3 Pivotal Data On Amgen's Novel Investigational CholesterolLowering...
THOUSAND OAKS Calif. March 24 2014 PRNewswire Amgen NASDAQAMGN today announced that it will present pivotal Phase 3 data from five clinical studies evaluating evolocumab AMG 145 an investigational...
View ArticleFebruary's Top 10 Medical Apps for the iPhone
By Iltifat HusainAnother month another scouring of the App Store for the release of new medical apps that could be of use for medical professionals. The highlight of this list is the free...
View ArticleLipitor MDL Approved for Type 2 Diabetes Litigation McSweeney Langevin...
Federal litigation involving Pfizer&39;s cholesterollowering drug Lipitor has been consolidated before a single judge in South Carolina.PRWEB March 25 2014 The law firm McSweeney Langevin continues...
View ArticleNew Guidelines Could Add 12.8 Million New Statin Users
The new American College of CardiologyAmerican Heart Association ACCAHA guidelines for managing cholesterolif adhered to strictlywould increase the number of adults eligible for statin therapy by 12.8...
View ArticleStatin Expansion Hold the Rx
Dr. Rita Redberg explains her New York Times oped against the increased use of statins and the neglected role of a healthy diet and exercise. Medscape Cardiology
View ArticleBococizumab RN316 Significantly Reduced LDL Cholesterol In StatinTreated...
Results Presented at the American College of Cardiologys ACC 63rd Annual Scientific Session in Washington D.C. Phase 3 Program Focused on CV Outcomes in Patient Populations at High Risk for...
View ArticlePfizer reports Phase IIb data for PCSK9 inhibitor
Pfizer Inc. NYSEPFE said subcutaneous bococizumab PF4950615 met the primary endpoint of reducing LDLC from baseline to week 12 vs. placebo in a Phase IIb trial to treat hypercholesterolemia in patients...
View ArticleAbaxis Receives CLIA Waiver For Capillary Sampling For Cholesterol HDL And...
UNION CITY Calif. March 28 2014 PRNewswire Abaxis Inc. NasdaqGS ABAX a medical products company manufacturing pointofcare blood analysis systems today announced the Food and Drug Administration granted...
View ArticlePfizer drug helps patients with hardtotreat cholesterol
Pfizer has announced results from a Phase 2b study of bococizumab its candidate for patients with hardtotreat raised cholesterol.Bococizumab RN316 is one of a new class of drugs which inhibit PCSK9 a...
View Article